IntoCell, Inc. (KOSDAQ:287840)
South Korea · Delayed Price · Currency is KRW 17,600
-590 (-3.24%)
At close: Sep 3, 2026
IntoCell Market Cap
IntoCell has a market cap or net worth of 274.3 billion as of September 4, 2026. Its market cap has decreased by -42.36% in one year.
Market Cap
274.30B
Enterprise Value
260.60B
Revenue
3.19B
Ranking
n/a
PE Ratio
n/a
Stock Price
17,600.00
ChartMarket Cap Chart
Since May 23, 2025, IntoCell's market cap has decreased from 492.33B to 274.30B, a decrease of -44.28%. That is a compound annual growth rate of -36.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 274.30B | -68.14% |
| Dec 30, 2025 | 861.05B | 74.89% |
| May 23, 2025 | 492.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ROKIT Healthcare | 427.16B |
| Curocell | 366.97B |
| Inventage Lab | 365.96B |
| HansBiomed | 283.80B |
| S.Biomedics | 235.32B |
| IMBiologics | 218.95B |
| Kangstem Biotech | 213.03B |
| curacle co.,ltd. | 211.97B |